Aktie CYTRX CORPORATION
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen CytRx Corporation Nasdaq

Aktien

US2328285091

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
LadRx: Q1 Earnings Snapshot
LadRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
LadRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
FDA Acceptance of Zevra's Arimoclomol NDA Filing for Niemann-Pick Disease Type C Results in XOMA Making a $1 Million Milestone Payment to LadRx
Xoma to Make $1 Million Milestone Payment to LadRx After FDA Accepts Zevra Application for Arimoclomol
LadRx Issues 2024 Update to Shareholders
LadRx: Q3 Earnings Snapshot
LadRx Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
LadRx : Modification to Rights of Security Holders - Form 8-K
LadRx: Q2 Earnings Snapshot
LadRx Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Investor Presentation: July 2023
LadRx Completes Non-Dilutive Financing Transaction for up to $11 Million with XOMA Corporation
LadRx Announces Reverse Stock Split Effective as of May 17, 2023
LadRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
LadRx Announces Reverse Stock Split
LadRx Corporation has filed an IPO in the amount of $24 million.
LadRx Highlights Patent Issued for Its LADR Technology
LadRx Highlights Patent Issued for Its LADR Technology
LadRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3ECEP Aktie
  4. Aktie
  5. Nachrichten CytRx Corporation
  6. Andere Sprachen